Noor Trends News, Technical Analysis, Educational Tools and Recommendations
Biotech company Gilead Sciences said it will be able to produce enough anti-coronavirus drug Remdesivir to meet global demand in October. In addition, Gilead said it plans to produce more than 2 million “treatment courses” for the drug by the end of the year, and expects to be able to …
Read More »Gilead Sciences: We’ll Be Able to Make Enough Remdesivir in October
